CatalystWireBeta

Funding of EBT to Acquire Ordinary Shares and RPT

In brief · summary, not quotable

Synectics plc announced its intention to fund its employee benefit trust with up to £1.5 million to facilitate market purchases of its ordinary shares, which will be held by the trust to satisfy future employee share-based compensation awards. This transaction is considered a related party transaction as the Chief Financial Officer is a director of the trustee, and other directors may be beneficiaries. The independent directors, in consultation with the nominated adviser, have confirmed that the terms of the transaction are fair and reasonable for the company's shareholders.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your SNX notes

Synectics plc (AIM: SNX), a leader in advanced security and surveillance solutions, announces that the Company intends to fund its employee benefit trust ("EBT") with up to £1.5 million in order for Quadnetics Employees' Trustees Limited, the Trustee of the EBT (the "Trustee"), to make market purchases of ordinary shares of 20 pence each in the Company ("Ordinary Shares"). The Ordinary Shares purchased by the Trustee will then be held by the EBT to satisfy future employee share-based compensation awards.

The Trustee will instruct Singer Capital Markets ("SCM"), as broker, to acquire the Ordinary Shares for the EBT. Purchases will be up to £1.5 million in value of Ordinary Shares (by market value and exclusive of stamp duty and commissions). Paul Williams, Chief Financial Officer and Director of Synectics, is also a Director of the Trustee.

Related Party Transaction

As certain Directors of the Company are potential beneficiaries of the market purchases of Ordinary Shares by the EBT, as well as Paul Williams being a Director of the Trustee of the EBT, the EBT is deemed to be a related party of the Company. The funding by the Company of the EBT to make such market purchases of Ordinary Shares is deemed to constitute a related party transaction under AIM Rule 13.

The independent Directors of the Company (being all Directors excluding Amanda Larnder, Chief Executive Officer and Paul Williams), having consulted with the Company's nominated adviser SCM, confirm that they consider that the terms of the transaction are fair and reasonable insofar as the Company's shareholders are concerned.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note